Angiogenic and inflammatory biomarkers for screening and follow-up in patients with pulmonary arterial hypertension

Abstract

Plasma levels of PlGF, sVEGFR-1, TNF-α, and VEGF-D have potential in screening for SSc-associated PAH. Plasma sVEGFR-1 may be a biomarker of treatment response.